About Charlotte Parker

This author has not yet filled in any details.
So far Charlotte Parker has created 2907 blog entries.

Attitudes Toward HPV Vaccination For Boys

Source: Medical News Today Date: 01 Feb 2013   A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents/guardians were receptive toward vaccinating boys against Human Papilloma Virus (HPV). However, racial/ethnic differences emerged in attitudes regarding school-entry mandates. The findings appear online in the journal Clinical Pediatrics. Although low-income and minority men have higher rates of oral HPV infection and are more likely to suffer from HPV-related diseases including penile, anal and oral cancers, few studies have examined parental attitudes after the HPV vaccine was approved for males in 2009. This study aimed to provide an in-depth understanding of how low-income and minority parents view HPV vaccination for boys using open-ended interview questions. The analysis was based on the Health Belief Model which measures perceived severity, susceptibility, benefits and barriers. Researchers led by corresponding author, Rebecca Perkins, MD, MSc, assistant professor of obstetrics and gynecology at BUSM, interviewed 120 parents and legal guardians of boys age 11 to 17 who accompanied them for physician visits between December 2011-2012. All subjects were read a short educational paragraph explaining HPV and HPV vaccination prior to answering questions. Perceiving the severe consequences of being exposed to HPV, most parents/guardians saw more benefits than barriers to vaccinating boys against HPV. Researchers found the most prominent barrier to vaccination was lack of information about the long-term efficacy and safety of the vaccine, specifically for males. "This study indicates that most parents would accept HPV vaccination for their sons just [...]

2013-02-04T11:56:10-07:00February, 2013|Oral Cancer News|

Should You Get the HPV Vaccine?

You don’t have to be a virgin to be protected against cancer. By Jake Blumgart|Posted Friday, Jan. 25, 2013, at 1:22 PM ET Source: Slate A doctor gives a 13-year-old girl an HPV vaccination Photo by Joe Raedle/Getty Images. The human papillomavirus has the dubious distinction of being the sexually transmitted disease you are most likely to get. It’s also the leading cause of cervical cancer. January has, somewhat arbitrarily, been dubbed Cervical Health Awareness Month (also National Hobby Month and Hot Tea Month, the last at least for good reason). While cervical cancer is the disease most commonly associated with HPV, a recent report from the American Cancer Society emphasizes that HPV’s threat is not gender-specific or organ-specific. While cervical cancer cases are in decline (as are general cancer rates), cancers linked to HPV are on the rise. The increasing prevalence of HPV-linked cancers should permanently alter our limited conception of the disease as chiefly a women’s issue. Oropharyngeal (which I’ll be vulgarizing as “oral”) and anal HPV-related cancers (which particularly afflict men who have sex with men) are becoming more common. Oral malignancies account for 37.3 percent of HPV-related cancers, edging out cervical cancer, which makes up 32.7 percent. For men, oral cancers make up 78.2 percent of total HPV-related cancer incidences, and they account for 11.6 percent of cases among women. The death rate for oral cancer is three times higher than that for cervical cancer. (About 40 percent of penile cancer cases are HPV-related, but rates [...]

2013-01-28T14:28:34-07:00January, 2013|OCF In The News, Oral Cancer News|

HPV vaccine issue returns to legislature

Source: abcnews4.com Date: January 14, 2013 by Stacy Jacobson CHARLESTON, S.C. (WCIV) -- A local state representative will introduce a bill that would give middle school students better accessibility to information about the Human Papilloma Virus vaccine and to the vaccine itself. Gov. Nikki Haley vetoed the bill last year. But lawmakers wanted to try again. HPV can cause cervical cancer, as well as head and neck cancer, doctors said. Therese Speer is a mother of three, and grandmother of four. She knew what it was like to worry as a parent. "More information is always a benefit to parents. The more you know, the more informed decision you can make," Speer said. She said she supports a new bill called the Cervical Cancer Prevention Act. Rep. Bakari Sellers (D-90th District) proposed it. "The CDC just stated the cost of cervical cancer in South Carolina is upwards of $25 million. This is something we can head off," Sellers said. The bill would make information about the HPV vaccine more available to seventh grade students. The bill would also allow the South Carolina Department of Health and Environmental Control to offer the vaccine through school. "When that information is provided and parents have opportunity to speak to pediatrician about this vaccine, they overwhelmingly accept it," MUSC gynecologic oncologist Dr. Jennifer Young-Pierce said. Officials said the bill had no mandates, only options. "Too often, people get info from friend or Internet that doesn't have the most up-to-date information. This is requiring us to provide information [...]

2013-01-16T11:27:50-07:00January, 2013|Oral Cancer News|

Dysphagia after definitive radiotherapy for head and neck cancer

Source: Strahlentherapie und Onkologie Authors: L. Deantonio MD, L. Masini MD, M. Brambilla PhD, F. Pia MD, M. Krengli MD Background Dysphagia is a complication of head and neck cancer patients undergoing radiotherapy (RT). We analysed frequency and severity of swallowing dysfunction and correlated these findings with dose–volume histograms (DVHs) of the pharyngeal constrictor muscles. Methods A total of 50 patients treated by radical RT were enrolled. DVHs of constrictor muscles were correlated with acute and late dysphagia and with the items of three quality of life questionnaires. Results Mean dose to superior and middle constrictor muscles (SCM, MCM), partial volume of SCM and MCM receiving a dose ≥ 50 Gy dose to the whole constrictor muscles ≥ 60 Gy and tumour location were associated to late dysphagia at univariate analysis. Mean dose to the MCM was the only statistically significant predictor of late dysphagia at the multivariable analysis. Conclusion The study shows a significant relationship between long-term dysphagia and mean doses to SCM, MCM, whole constrictor muscles, and oropharyngeal tumour. This finding suggests a potential advantage in reducing the RT dose to swallowing structures to avoid severe dysphagia.  This article was sourced by The Oral Cancer Foundation and vetted for accuracy and appropriateness.

2013-01-14T20:58:52-07:00January, 2013|Oral Cancer News|

Why can’t doctors tell cancer patients the truth?

Source: SALON.com By: Mary Elizabeth Williams     Medical journals and physicians underplay what treatment is really like. And it hurts patients (Credit: Henk Vrieselaar via Shutterstock) Everyone appreciates a bright perspective, especially in grim circumstances. But you know what’s a really poor arena for downplaying the bad news? Medicine. A new report in the Annals of Oncology this week reveals that in two thirds of breast cancer studies, side effects were downplayed – including serious ones. And, as Reuters reports, it’s a field-wide problem in the health care industry: Last fall, cardiology journal editors warned authors to “watch their language” in reporting, and pediatrics researchers warned of “spin and boasting” in their journals. Aside from the ethical issues of publishing misleading information, the habit of rushing to make it all seem better has serious consequences. Because the sunnyside talk doesn’t stop at the journals. It trickles over to doctors, who then minimize what a patient’s real experience is going to be like. And even without overly optimistic literature to inspire them, doctors and their lack of understanding can be an issue. A 2007 study in the journal Drug Safety found that over 60 percent of patients who complained of side effects to a particular drug said “their doctors did not appreciate the impact the symptoms had on their quality of life.” At the time, health policy professor Albert W. Wu told American Medical News that doctors “have the bad habit of discounting patients’ complaints. In our desire not to worry [...]

2013-01-11T15:03:36-07:00January, 2013|Oral Cancer News|

Another Side Effect Of Chemotherapy: ‘Chemo Brain’

Source: NPR Date: December 28, 2012 Author:  Patti Neighmond   It's well-known that chemotherapy often comes with side effects like fatigue, hair loss and extreme nausea. What's less well-known is how the cancer treatment affects crucial brain functions, like speech and cognition. For Yolanda Hunter, a 41-year-old hospice nurse, mother of three and breast cancer patient, these cognitive side effects of chemotherapy were hard to miss. "I could think of words I wanted to say," Hunter says. "I knew what I wanted to say. ... There was a disconnect from my brain to my mouth." Before getting treated for cancer, Hunter led a busy, active lifestyle. But the effects of chemotherapy on her brain made it difficult for her to do even the most basic things. "I couldn't even formulate a smile. I had no expression," she says. "I might feel things on the inside, but it didn't translate to the outside. ... It literally felt like you were trying to fight your way through fog." Some cancer patients call this mental fog "chemo brain." And now researchers are trying to quantify exactly what chemo brain really is. Oncologist Jame Abraham, a professor at West Virginia University, says about a quarter of patients undergoing chemotherapy have trouble processing numbers, using short-term memory and focusing their attention. Using positron emission tomography, or PET, scans to measure blood flow and brain activity, Abraham looked at the brains of 128 breast cancer patients before they started chemotherapy and then again, six months later. On [...]

2013-01-10T13:00:01-07:00January, 2013|Oral Cancer News|

A tragic turn of events to most important dental story published in 2012

Source: DentistryIQ Date: 12/21/2012 By Maria Perno Goldie, RDH, MS, and Jo-Anne Jones, RDH Jo-Anne Jones, RDH, President, RDH Connection Inc., has much to be proud of! An article by Jo-Anne, about a possible connection between sex and oral cancer, has been selected by the dental editors of PennWell publications as the most important article published in 2012 for the dental profession. Jones’ article, “Sex and oral cancer: What is the connection?” appeared in the April 6 issue of RDH eVillage FOCUS e-newsletter. The article shares some of the latest statistics regarding a possible connection between the human papillomavirus (HPV) and oral cancer. To read the article, click here. The editors participating in the selection of the top published dental story perform editorial duties for Dental Economics, RDH, and Proofs magazines, as well as Dental Assisting Digest, RDH eVillage, RDH eVillage FOCUS, DE Expert Tips & Tricks, Surgical-Restorative Resource, and New Products electronic newsletters. Articles that were published in either print or electronic formats were accepted. Dental editors were asked to submit a nomination of the most important article from their respective publication. Nominations were sought for the following categories: • Most important article from Dental Assisting Digest • Most important article from Proofs • Most important article from RDH eVillage • Most important article from RDH eVillage FOCUS • Most important article from New Products • Most important article from Surgical-Restorative Resource • Most important article from DE Expert Tips & Tricks • Most important article from DentalEconomics.com • [...]

2012-12-21T10:56:21-07:00December, 2012|OCF In The News, Oral Cancer News|

The Oral Cancer Foundation Honored as 2012 Top-Rated Nonprofit

Source: The Oral Cancer Foundation New GreatNonprofits.org Award is Based on Positive Online Reviews NEWPORT BEACH, Calif., Dec. 14, 2012 /PRNewswire-USNewswire/ -- The Oral Cancer Foundation announced today that it has been honored with a prestigious 2012 Top-Rated Award by GreatNonprofits, the leading provider of user reviews about nonprofit organizations. "We are excited to be named a Top-Rated 2012 Nonprofit," says Brian Hill , Founder and Executive Director, The Oral Cancer Foundation.  "We are proud of our accomplishments this year, including the public service announcement we filmed with Actor and oral cancer survivor, Michael Douglas ." The Top-Rated Nonprofit award was based on the large number of positive reviews that OCF received – reviews written by volunteers, donors and clients. People posted their personal experience with the nonprofit.  For example, one person wrote, "I was 33 years old when I was diagnosed with Stage IV metastatic Oral Cancer. The treatments and surgeries that saved my life however left me disfigured, disabled, and dependent on the opiate pain medication, Fentanyl. I felt lost and alone, without hope. I found the Oral Cancer Foundation website 11 months after diagnosis and it was a ray of light for me. I was able to connect with survivors and other patients who understood my struggle and relate to where I was. With their advice and support I've been able to rebuild my body and free myself from the opiates, and begin to live again. I can't express the gratitude in my heart for the Oral Cancer [...]

2012-12-14T15:17:40-07:00December, 2012|OCF In The News|

The effect of treating institution on outcomes in head and neck cancer

Source: American Academy of Otolaryngology - Head and Neck Surgery Alexandria, VA — Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery. "Despite similar rates of treatment completion and rate of treatment breaks between groups, patients treated in academic centers had more advanced cancer but better survival," the authors state in their conclusion. The study evaluated differences in patient characteristics, treatment, and cancer outcomes in the head and neck cancer population at the University of Minnesota from 2002 through 2008. Data were gathered on demographics, general medical data, tumor variables, insurance type, marital status and health behaviors. The study analyzed 355 patients with mucosal head and neck cancer treated with radiation therapy from 2002 to 2008. One hundred forty-five (41%) received radiation treatment at community hospitals, and 210 (59%) were treated at academic hospitals. Within the academic hospitals group, 197 underwent radiation at the University of Minnesota, and 13 received radiation at an alternative academic center. Both treatment groups shared similar characteristics in regard to sex, comorbidity, marital status, work status, insurance, and alcohol use. However, the community group had more current smokers and slightly older patients on average. Patients in the academic group were more likely to live in an urban location and had a higher median income. Patients undergoing radiation treatment at university centers had significantly more advanced [...]

2012-12-07T12:47:56-07:00December, 2012|Oral Cancer News|

In Fine Print of Fiscal Debate, Charities Unite to Defend Deductions

Source: The New York Times Date: December 5, 2012 By ANNIE LOWREY WASHINGTON — Proposals to cap or otherwise limit deductions in order to raise tax revenue from the wealthy are gaining bipartisan support in Washington — and making charities and nonprofits very worried. Concerned that special tax benefits to encourage Americans to give to charity might be significantly curtailed in the negotiations between President Obama and Speaker John A. Boehner, scores of nonprofit leaders came to Washington this week for a coordinated lobbying effort. “Normally, every nonprofit is focused on its own particular mission, whether saving the environment, or helping children, or imbuing a greater appreciation for art,” said Diana Aviv, the chief executive of Independent Sector, an umbrella group for nonprofits that helped organize this week’s effort. “For the first time, I’ve seen the sector coming together. We’re like Rip Van Winkle waking up and saying, This is not O.K.!” At stake is the $300 billion that Americans donate to nonprofits every year — and the $50 billion a year that tax deductions for charitable giving costs the government. Both Republicans and Democrats say they want to maintain tax laws that encourage Americans to give money to nonprofit groups. But with the White House looking to raise an additional $1.6 trillion in revenue over 10 years, and Republicans looking to raise $800 billion, there is growing bipartisan support for peeling back some of the special breaks for high-income households. That prospect has spurred Ms. Aviv and other nonprofit leaders [...]

2012-12-06T13:25:04-07:00December, 2012|Oral Cancer News|
Go to Top